TNF AND MCP-1 IN RETROVIRUS-INDUCED BRAIN DISEASE

$218,775P20FY2004RRNIH

Louisiana State Univ A&M Col Baton Rouge, Baton Rouge LA

Investigators

Linked publications & trials

Paper 32899224 Paper 31057493 Paper 29242055 Paper 28336678 Paper 26349661 Paper 26349659 Paper 26270051 Paper 26248368 Paper 26234571 Paper 25977598 Paper 25769244 Paper 25730547 Paper 25549835 Paper 25355870 Paper 25322074 Paper 25197327 Paper 24962586 Paper 24743303 Paper 24705585 Paper 24696477 Paper 24490123 Paper 24312537 Paper 24198426 Paper 24047412 Paper 23802315 Paper 23787776 Paper 23359591 Paper 23311579 Paper 23281399 Paper 23255564 Paper 23221556 Paper 23152520 Paper 23033145 Paper 22606349 Paper 22547706 Paper 22543867 Paper 22535448 Paper 22484463 Paper 22429048 Paper 22425639 Paper 22402035 Paper 22330789 Paper 22291924 Paper 22235255 Paper 22143521 Paper 22127207 Paper 21994443 Paper 21781131 Paper 21622026 Paper 21543507 Paper 21490096 Paper 21426048 Paper 21304587 Paper 21298018 Paper 21279498 Paper 21209822 Paper 20824205 Paper 20701538 Paper 20459829 Paper 20395273 Paper 20394526 Paper 20386700 Paper 19998480 Paper 19955303 Paper 19656874 Paper 19521898 Paper 19493994 Paper 19376862 Paper 19358735 Paper 19306229 Paper 19168789 Paper 19149555 Paper 19079667 Paper 18988922 Paper 18957595 Paper 18833332 Paper 18714021 Paper 18678660 Paper 18676179 Paper 18579597 Paper 18490763 Paper 18480449 Paper 18479884 Paper 18452586 Paper 18372637 Paper 18195034 Paper 17855522 Paper 17709518 Paper 17507488 Paper 17392357 Paper 17303205 Paper 17266555 Paper 17178789 Paper 17041142 Paper 16966215 Paper 16893457 Paper 16875710 Paper 16872282 Paper 16641278 Paper 16641277

Abstract

The innate immune response to virus infection or protein aggregation in the brain has been implicated in the development of non-lymphocyte mediated neurological disorders such HIV-associated dementia (HAD), Alzheimer's disease. Increased expression of the proinflammatory cytokine TNFalpha and chemokine MCP-1 is often associated with clinical disease in HAD and AIzheimer's disease. Additionally, genetic polymorphism analysis linked high expression alleles of both TNFalpha and MCP-1 with increased risk for HAD. However, the mechanism by which these proteins contribute pathogenesis is not clear. Furthermore, it is unknown why TNFalpha and MCP-1 are upregulated in response to retrovirus infection. The current proposal will analyze the mechanism by which TNFalpha and MCP-1 contribute to neurological disease pathogenesis using a mouse model of retrovirus infection. Knockout mouse studies demonstrated that both TNFalpha and CCR2, the primary receptor for MCP-1, contribute to neurological disease in this model. In this proposal, we will determine if deficiency in either TNFalpha or CCR2 prevents the activation of other components of the innate immune response such as astrocyte or microglia activation and the induction of proinflammatory cytokine/chemokine responses. Additionally, we will also analyze the role of Toll-like receptors(TLR) in the induction of the cytokine/chemokine response to retrovirus infection in the brain. Initial studies indicate that TLR7, but not TLR3, is upregulated by neurovirulent virus infection in the brain. Thus, activation of the TLR7 pathway may induce the proinfiammatory cytokine/chemokine response associated with neurological disease. These studies how proinflammatory cytokines and chemokines are involved in non-inflammatory neurological diseases, leading the way for potential therapeutics that can inhibit entire pathways of activation, rather than trying to block soluble cytokines or chemokines.

View original record on NIH RePORTER →